Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,541.89
(
-0.98%
)
US TECH 100
23,352.40
(
-1.55%
)
Dow Jones
45,796.94
(
-0.49%
)
Brent Oil
106.97
(
2.43%
)
Bitcoin
69,954.01
(
0.08%
)
News Focus
News Focus

Replies to post #208593 on Biotech Values

Replies to #208593 on Biotech Values
icon url

DewDiligence

01/31/17 12:51 PM

#208594 RE: Biowatch #208593

It's curious that no FDA approval to date of an FoB under the 351(k) pathway has been an oncology drug. (I'm not counting Neupogen/Neulasta as oncology drugs because they don't treat cancer.)